The RHD(1227G>A) DEL-associated allele is the most prevalent DEL allele in Australian D- blood donors with C+ and/or E+ phenotypes

Transfusion

Volumn 54, Issue 11, 2014, Pages 2931-2940

  Scott, Stacy A ^a   Nagl, Lisa ^a   Tilley, Louise ^a   Liew, Yew Wah ^b   Condon, Jenny ^b   Flower, Robert ^a   Hyland, Catherine A ^a  

^a AUSTRALIAN RED CROSS BLOOD SERVICE   (Australia)

^b NHS BLOOD AND TRANSPLANT   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

RHESUS D ANTIBODY; RHESUS D ANTIGEN; BLOOD GROUP RHESUS SYSTEM; RHO(D) ANTIGEN;

ALLELE; ALLOIMMUNIZATION; ARTICLE; AUSTRALIAN; BLOOD DONOR; BLOOD SAMPLING; BLOOD TRANSFUSION; COHORT ANALYSIS; ERYTHROCYTE; EXON; GENE SEQUENCE; GENETIC ANALYSIS; GENOTYPE; HUMAN; NEWBORN HEMOLYTIC DISEASE; PHENOTYPE; POLYMERASE CHAIN REACTION; RISK; RISK FACTOR; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM; ADULT; AUSTRALIA; BIOLOGICAL MODEL; BLOOD GROUP INCOMPATIBILITY; BLOOD GROUP RHESUS SYSTEM; CLINICAL TRIAL; ERYTHROCYTE TRANSFUSION; FEMALE; GENE DELETION; GENE FREQUENCY; GENETICS; MALE; MULTICENTER STUDY; NUCLEOTIDE SEQUENCE; POINT MUTATION; PREVALENCE;

ADULT; ALLELES; AUSTRALIA; BASE SEQUENCE; BLOOD DONORS; BLOOD GROUP INCOMPATIBILITY; ERYTHROCYTE TRANSFUSION; FEMALE; GENE FREQUENCY; HUMANS; MALE; MODELS, GENETIC; POINT MUTATION; PREVALENCE; RH-HR BLOOD-GROUP SYSTEM; SEQUENCE DELETION;

EID: 84912534912     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/trf.12701     Document Type: Article

References (59)

1. Avent ND, Reid ME,. The Rh blood group system: a review. Blood 2000; 95: 375-387.
2. Chou ST, Westhoff CM,. The Rh and RhAG blood group systems. Immunohematology 2010; 26: 178-186.
3. Daniels G,. Chapter 5: Rh blood group system. In:, Daniels G, editor. Human blood groups. 2nd ed. Hoboken (NJ): Blackwell Science Ltd; 2002.
4. Chérif-Zahar B, Mattéi MG, Le Van Kim C, et al. Localization of the human Rh blood group gene structure to chromosome region 1p34.3-1p36.1 by in situ hybridization. Hum Genet 1991; 86: 398-400.
5. Colin Y, Chérif-Zahar B, Le Van Kim C, et al. Genetic basis of the RhD-positive and RhD-negative blood group polymorphism as determined by Southern analysis. Blood 1991; 78: 2747-2752.
6. Okuda H, Suganuma H, Kamesaki T, et al. The analysis of nucleotide substitutions, gaps, and recombination events between RHD and RHCE genes through complete sequencing. Biochem Biophys Res Commun 2000; 274: 670-683.
7. Wagner FF, Frohmajer A, Flegel WA,. RHD positive haplotypes in D negative Europeans. BMC Genet 2001; 2: 10-24.
8. Flegel WA, Khull SR, Wagner FF,. Primary anti-D immunization by weak D type 2 RBCs. Transfusion 2000; 40: 428-434.
9. Gorick B, McDougall DC, Ouwehand WH, et al. Quantitation of D sites on selected "Weak D" and "Partial D" red cells. Vox Sang 1993; 65: 136-140.
10. Wagner FF, Frohmajer A, Ladewig B, et al. Weak D alleles express distinct phenotypes. Blood 2000; 95: 2699-2708.
11. Daniels G,. Variants of RhD-current testing and clinical consequences. Br J Haematol 2013; 161: 461-470.
12. Okubo Y, Yamaguchi H, Tomita T, et al. A D variant Del? Transfusion 1984; 24: 542.
13. Brajovich ML, Trucco BC, Nogués N, et al. Abstract 70: molecular basis of D negative phenotype in the population of rosario. BIOCELL 2012; 36: A15-A34.
14. Christiansen M, Sørensen BS, Grunnet N,. RHD positive among C/E+ and D- blood donors in Denmark. Transfusion 2010; 50: 1460-1464.
15. Flegel WA, von Zabern I, Wagner FF,. Six years' experience performing RHD genotyping to confirm D- red blood cell units in Germany for preventing anti-D immunizations. Transfusion 2009; 49: 465-471.
16. el (d-elute) using polymerase chain reaction (PCR) with RHD gene-specific primers. Transfusion 1997; 49: 465-471.
17. Gassner C, Doescher A, Drnovsek TD, et al. Presence of RHD in serologically D-, C/E+ individuals: a European multicenter study. Transfusion 2005; 45: 527-538.
18. Kim JY, Kim SY, Kim C-A, et al. Molecular characterization of D- Korean persons: development of a diagnostic strategy. Transfusion 2005; 45: 345-352.
19. Krog GR, Clausen FB, Berkowicz A, et al. Is current serologic RhD typing of blood donors sufficient for avoiding immunization of recipients? Transfusion 2011; 51: 2278-2285.
20. Li Q, Hou L, Guo Z-H, et al. Molecular basis of the RHD gene in blood donors with DEL phenotypes in Shanghai. Vox Sang 2009; 97: 139-146.
21. Luettringhaus TA, Cho D, Ryang DW, et al. An easy RHD genotyping strategy for D- East Asian persons applied to Korean blood donors. Transfusion 2006; 46: 2128-2137.
22. Orzińska A, Guz K, Polin H, et al. RHD variants in Polish blood donors routinely typed as D-. Transfusion 2013; 53 (11 Suppl 2): 2945-2953.
23. Polin H, Danzer M, Gaszner W, et al. Identification of RHD alleles with the potential of anti-D immunization among seemingly D- blood donors in Upper Austria. Transfusion 2009; 49: 676-681.
24. Wagner FF,. RhesusBase. 2012. [cited 2014 Apr 1]. Available from: http://rhesusbase.atspace.com.
25. Yang Y-F, Wang Y-H, Chen J-C, et al. Prevalence of RHD 1227A and hybrid Rhesus box in the general Chinese population. Transl Res 2007; 149: 31-36.
26. u) and partial D. British Blood Transfusion Society: Blood Bank Technology Group Meeting 1993: 4-6.
27. Kim K-H, Kim K-E, Woo K-S, et al. Primary anti-D immunization by DEL red blood cells. Korean J Lab Med 2009; 29: 361-365.
28. Shao C-P, Wang B-Y, Ye S-H, et al. DEL RBC transfusion should be avoided in particular blood recipients in East Asia due to allosensitization and ineffectiveness. J Zhejiang Univ Sci B 2012; 13: 913-918.
29. Tsutsumi. PA-1-21: anti-D antibody production in Rh0 (D) by Del MAP blood transfusion. 2006. Department of Clinical Laboratory, Mie Chuo Medical Centre.
30. Wagner T, Körmöczi GF, Buchta C, et al. Anti-D immunization by DEL red blood cells. Transfusion 2005; 45: 520-526.
31. el red blood cells. Transfusion 2005; 45: 1581-1584.
32. Wagner FF,. RHD PCR of D-negative blood donors. Transfus Med Hemother 2013; 40: 172-181.
33. Finning KM, Martin PG, Soothill PW, et al. Prediction of fetal D status from maternal plasma: introduction of a new noninvasive fetal RHD genotyping service. Transfusion 2002; 42: 1079-1085.
34. Lo YM, Hjelm NM, Fidler C, et al. Prenatal diagnosis of fetal RhD status by molecular analysis of maternal plasma. N Engl J Med 1998; 339: 1734-1738.
35. Hyland CA, Gardener GJ, Davies H, et al. Evaluation of non-invasive prenatal RHD genotyping of the fetus. Med J Aust 2009; 191: 21-25.
36. Finning K, Martin P, Daniels G,. Chapter 11: the use of maternal plasma for prenatal RhD blood group genotyping. In:, Bugert P, editor. DNA and RNA profiling in human blood: methods and protocols. New York: Humana Press; 2008.
37. Azkarate M, Santos S, Renovales A, et al. Abstract 2D-S10-05: mass-scale genotyping of RBC donors in the basque country. Vox Sang 2009; 96: 1-62.
38. el and weak D phenotypes in Chinese. Vox Sang 2002; 83: 156-161.
39. Szulman A, Nardozza LM, Barreto JA, et al. Investigation of pseudogenes RHDΨ and RHD-CE-D hybrid gene in D-negative blood donors by the real time PCR method. Transfus Apher Sci 2012; 47: 289-293.
40. Chou ST, Westhoff CM,. Molecular biology of the Rh system: clinical considerations for transfusion in sickle cell disease. American Society of. Hematology 2009; 1: 178-184.
41. Andrews KT, Wolter LC, Saul A, et al. The RhD- trait in a white patient with the RhCCee phenotype attributed to a four-nucleotide deletion in the RHD gene. Blood 1998; 92: 1839-1840.
42. Chen J-M, Fichou Y, Jamet D, et al. Small deletions within the RHD coding sequence: a report of two novel mutational events and a survey of the underlying pathophysiologic mechanisms. Transfusion 2013; 53: 206-210.
43. Haer-Wigman L, Veldhuisen B, Jonkers R, et al. RHD and RHCE variant and zygosity genotyping via multiplex ligation-dependent probe amplification. Transfusion 2013; 53: 1559-1574.
44. Körmöczi GF, Gassner C, Shao C-P, et al. A comprehensive analysis of DEL types: partial DEL individuals are prone to anti-D alloimmunization. Transfusion 2005; 45: 1561-1567.
45. Mota M, Dezan M, Valgueiro MC, et al. RHD allelic identification among D- Brazilian blood donors as a routine test using pools of DNA. J Clin Lab Anal 2012; 26: 104-108.
46. Singleton BK, Green CA, Kimura K, et al. Abstract S02-004: two new RHD mutations associated with the DEL phenotype. Transfus Clin Biol 2001; 8: 8s-10s.
47. Araszkiewicz P, Szymanski O,. Quantitative studies on the Rh-antigen D: effect of the C gene. Transfusion 1987; 27: 257-261.
48. Rochna E, Hughes-Jones NC,. The use of purified 125I-labelled Anti-γ globulin in the determination of the number of D antigen sites on red cells of different phenotypes. Vox Sang 1965; 10: 675-686.
49. Wagner FF,. Influence of Rh phenotype on the antigen density of C, c, and D: flow cytometric study using a frozen standard red cell. Transfusion 1994; 34: 671-676.
50. Scott M,. Section 1A: Rh serology coordinator's report. Transfusion Clinique et Biologique 2002; 9: 23-29.
51. Fichou Y, Maréchal CL, Bryckaert L, et al. Variant screening of the RHD gene in a large cohort of subjects with D phenotype ambiguity: report of 17 novel rare alleles. Transfusion 2012; 52: 759-764.
52. Richard M, Perreault J, Constanzo-Yanez J, et al. A new DEL variant caused by exon 8 deletion. Transfusion 2007; 47: 852-857.
53. National Blood Authority Australia. Annual report 2011-2012; 2012.
54. CSL Ltd. Epiclone anti-DCE: common Rh phenotypes and genotypes. Product leaflet. Parkville, Vic, Australia: CSL Ltd.; 2007.
55. Comande M, Waters N, Polizzotto MN, et al. Informing emergency blood supply contingency planning: bloodhound on the trail. Annual Scientific Meeting of HAA. 2010. Australian Red Cross Blood Service.
56. Australian Bureau of Statistics. 20680-ancestry (region) by country of birth of parents-Australia. 2006. Available from: http://www.censusdata.abs.gov.au.
57. Denomme GA,. Prospects for the provision of genotyped blood for transfusion. Br J Haematol 2013; 163: 3-9.
58. Peyrard T,. Use of genomics for decision-making in transfusion medicine: laboratory practice. ISBT Sci Ser 2013; 8: 11-15.
59. Westhoff CM,. Molecular DNA-based testing for blood group antigens: recipient-donor focus. ISBT Sci Ser 2013; 8: 1-5.